Fig. 5

HIGD1A, SUCLG2, and SLC25A24 could complement each other’s detection results in various subtypes of benign and malignant colorectal tumors. The mRNA expression of a SLC25A24, HIGD1A and SUCLG2 in unique CRC datasets of Oncomine, and b SLC25A24, c HIGD1A, and d SUCLG2 in different subtypes of colorectal tumors. e The expression rank of HIGD1A, SUCLG2, and SLC25A24 in various subtypes of colorectal tumors. The colors represent the gene-rank percentile for the investigations within the cell